IBM and Nvidia move quantum processors into supercomputing workflows
New Slurm integration, a Fermilab co-design platform and GPU-accelerated error-correction tools aim to make quantum processors usable inside established HPC environments.
AI / NEWS BRIEF
Google has moved its screenshot-driven Computer Use tool out of preview across the Gemini Interactions and GenerateContent APIs, while retaining strong supervision warnings.
Google's October 30 Gemini API changelog moves Computer Use to general availability across both the Interactions and GenerateContent APIs. The tool lets developers build agents for browser, mobile and desktop interfaces: a Gemini model reads screenshots and proposes actions such as clicks, scrolling and keyboard input, while the developer's own client executes those actions and returns the next screenshot.
Google documents configurable safety policies, action-level safety decisions and optional screenshot scanning for prompt injection. It still warns that Computer Use can contain errors and security vulnerabilities, recommends close supervision for important work, and advises against using it for critical decisions, sensitive data or actions whose mistakes cannot be corrected. Google also recommends running the execution environment inside a sandboxed virtual machine or container.
The change is material for developers because Computer Use is now presented as a supported Gemini API capability rather than a preview feature. It does not establish reliability on any particular workflow: Google provides no accuracy result, pricing detail specific to this tool or evidence on these pages that it can safely complete unsupervised high-stakes tasks. AIQuantumScore has not independently run the tool, and the availability change does not create a model benchmark or REVAL score.
New Slurm integration, a Fermilab co-design platform and GPU-accelerated error-correction tools aim to make quantum processors usable inside established HPC environments.
OpenAI has released healthcare-focused computer-use capabilities across its API and clinical products, with configurable approvals, audit logs and new performance results that remain provider-reported.